Prevalence and pathophysiologic attributes of ventricular dyssynchrony in arrhythmogenic right ventricular dysplasia/cardiomyopathy.

OBJECTIVES This study sought to investigate the prevalence and mechanisms underlying right ventricular (RV) dyssynchrony in arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) using tissue Doppler echocardiography (TDE). BACKGROUND An ARVD/C is characterized by fibrofatty replacement of RV myocardium and RV dilation. These pathologic changes may result in electromechanical dyssynchrony. METHODS Echocardiography, both conventional and TDE, was performed in 52 ARVD/C patients fulfilling Task Force criteria and 25 control subjects. The RV end-diastolic and -systolic areas, right ventricular fractional area change (RVFAC), and left ventricular (LV) volumes and function were assessed. Mechanical synchrony was assessed by measuring differences in time-to-peak systolic velocity (T(SV)) between the RV free wall, ventricular septum, and LV lateral wall. An RV dyssynchrony was defined as the difference in T(SV) between the RV free wall and the ventricular septum, >2 SD above the mean value for control subjects. RESULTS The mean difference in RV T(SV) was higher in ARVD/C compared with control subjects (55 +/- 34 ms vs. 26 +/- 15 ms, p < 0.001). Significant RV dyssynchrony was not noted in any of the control subjects. Based on a cutoff value of 56 ms, significant RV dyssynchrony was present in 26 ARVD/C patients (50%). Patients with RV dyssynchrony had a larger RV end-diastolic area (22 +/- 5 cm(2) vs. 19 +/- 4 cm(2), p = 0.02), and lower RVFAC (29 +/- 8% vs. 34 +/- 8%, p = 0.03) compared with ARVD/C patients without RV dyssynchrony. No differences in QRS duration, LV volumes, or function were present between the 2 groups. CONCLUSIONS An RV dyssynchrony may occur in up to 50% of ARVD/C patients, and is associated with RV remodeling. This finding may have therapeutic and prognostic implications in ARVD/C.

[1]  Christophe Leclercq,et al.  Echocardiographic evaluation of cardiac resynchronization therapy: ready for routine clinical use? A critical appraisal. , 2004, Journal of the American College of Cardiology.

[2]  X. Jouven,et al.  Natural History and Risk Stratification of Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy , 2004, Circulation.

[3]  Jeroen J. Bax,et al.  Left ventricular dyssynchrony predicts response and prognosis after cardiac resynchronization therapy. , 2004, Journal of the American College of Cardiology.

[4]  S. Russell,et al.  Utility of tissue Doppler and strain echocardiography in arrhythmogenic right ventricular dysplasia/cardiomyopathy. , 2007, The American journal of cardiology.

[5]  M. Simon,et al.  Right ventricular dyssynchrony in heart failure: a tissue Doppler imaging study. , 2006, Journal of cardiac failure.

[6]  N. Freemantle,et al.  Baseline echocardiographic characteristics of heart failure patients enrolled in a large European multicentre trial (CArdiac REsynchronisation Heart Failure study). , 2006, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

[7]  Christophe Leclercq,et al.  Cardiac resynchronization therapy: Part 1--issues before device implantation. , 2005, Journal of the American College of Cardiology.

[8]  Michel Haïssaguerre,et al.  Intra-left ventricular electromechanical asynchrony. A new independent predictor of severe cardiac events in heart failure patients. , 2004, Journal of the American College of Cardiology.

[9]  G. Danieli,et al.  Mutation in human desmoplakin domain binding to plakoglobin causes a dominant form of arrhythmogenic right ventricular cardiomyopathy. , 2002, American journal of human genetics.

[10]  Richard B Devereux,et al.  Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardio , 2005, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[11]  A. Ng,et al.  Left ventricular longitudinal and radial synchrony and their determinants in healthy subjects. , 2008, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[12]  Jeroen J. Bax,et al.  Echocardiographic evaluation of cardiac resynchronization therapy: Ready for routine clinical use? , 2004 .

[13]  A. Nava,et al.  Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology. , 1994, British heart journal.

[14]  Jeroen J. Bax,et al.  Relationship Between QRS Duration and Left Ventricular Dyssynchrony in Patients with End‐Stage Heart Failure , 2004, Journal of cardiovascular electrophysiology.

[15]  T. Abraham,et al.  Role of tissue Doppler and strain echocardiography in current clinical practice. , 2007, Circulation.

[16]  M. Davies,et al.  Spectrum of clinicopathologic manifestations of arrhythmogenic right ventricular cardiomyopathy/dysplasia: a multicenter study. , 1997, Journal of the American College of Cardiology.

[17]  S. Goodman,et al.  Cardiac resynchronization and death from progressive heart failure: a meta-analysis of randomized controlled trials. , 2003, JAMA.

[18]  Randy Martin,et al.  Echocardiography for cardiac resynchronization therapy: recommendations for performance and reporting--a report from the American Society of Echocardiography Dyssynchrony Writing Group endorsed by the Heart Rhythm Society. , 2008, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[19]  J. Gorcsan,et al.  Right ventricular dyssynchrony in patients with pulmonary hypertension is associated with disease severity and functional class , 2005, Cardiovascular ultrasound.

[20]  Catherine Klersy,et al.  Interventricular and intraventricular dyssynchrony are common in heart failure patients, regardless of QRS duration. , 2004, European heart journal.

[21]  S. Hunt,et al.  Right Ventricular Function in Cardiovascular Disease, Part II: Pathophysiology, Clinical Importance, and Management of Right Ventricular Failure , 2008, Circulation.

[22]  Walter Birchmeier,et al.  Mutations in the desmosomal protein plakophilin-2 are common in arrhythmogenic right ventricular cardiomyopathy , 2004, Nature Genetics.

[23]  D. Kass An epidemic of dyssynchrony: but what does it mean? , 2008, Journal of the American College of Cardiology.

[24]  G. Danieli,et al.  Mutations in Desmoglein-2 Gene Are Associated With Arrhythmogenic Right Ventricular Cardiomyopathy , 2006, Circulation.

[25]  S. Russell,et al.  Arrhythmogenic Right Ventricular Dysplasia: A United States Experience , 2005, Circulation.

[26]  K. Dohi,et al.  Relation of right ventricular free wall mechanical delay to right ventricular dysfunction as determined by tissue Doppler imaging. , 2005, The American journal of cardiology.

[27]  N. Reichek,et al.  Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. , 1989, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[28]  M. Schalij,et al.  Arrhythmogenic right ventricular dysplasia/cardiomyopathy: screening, diagnosis, and treatment. , 2006, Heart rhythm.